House Bill
H.R. 4099
Ensuring Women’s Right to Reproductive Freedom Act
Primary Sponsor

H. Morgan Griffith
Representative
Cosponsors
2
Quick Stats
Policy Area
Summary
This bill would renew and extend several programs run by the Centers for Disease Control and Prevention to address the opioid crisis. It would continue funding for evidence-based prevention grants, prescription drug monitoring, and public education campaigns. The bill also specifically includes the fentanyl crisis as a new priority for these programs.
Latest Action
Referred to the Subcommittee on Health.
See this page through your district lens
Enter ZIP to personalize representatives and vote context.
Stay on top of this issue
Subscribe for weekly bill and representative updates.
Vote Prediction
Ensuring Women’s Right to Reproductive Freedom Act
This bill would renew and extend several programs run by the Centers for Disease Control and Prevention to address the opioid crisis. It would continue funding for evidence-based prevention grants, prescription drug monitoring, and public education campaigns.
Community Breakdown
Pass
0%
Fail
0%
0 predictions
This bill would renew and extend several programs run by the Centers for Disease Control and Prevention to address the opioid crisis. It would continue funding for evidence-based prevention grants, prescription drug monitoring, and public education campaigns. The bill also specifically includes the fentanyl crisis as a new priority for these programs.
- Bill Number
- 4099
- Sponsor
- H. Morgan Griffith (R-VA)
- Introduced
- 6/24/2025
- Status
- Referred to the House Committee on Energy and Commerce.
- Policy Area
- Health
Data from Congress.gov
Fact Sheet
- Title
- Ensuring Women’s Right to Reproductive Freedom Act
- Bill Number
- 4099
- Sponsor
- H. Morgan Griffith (R-VA)
- Status
- Referred to the House Committee on Energy and Commerce.
- Introduced
- 6/24/2025
- Summary
- This bill would renew and extend several programs run by the Centers for Disease Control and Prevention to address the opioid crisis. It would continue funding for evidence-based prevention grants, prescription drug monitoring, and public education campaigns. The bill also specifically includes the
Data from Congress.gov
Public Opinions
Community submissions related to this bill.
No public opinions yet. Be the first to submit one for this bill.
Related Bills in Health
Empowering Patient Choice of Medical Care Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means
To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
Referred to the House Committee on Energy and Commerce.
Anti-Racism in Public Health Act of 2025
Referred to the House Committee on Energy and Commerce.
SOAR Act of 2025
Read twice and referred to the Committee on Finance.